Tuberculosis in HIV-infected Tanzanian children below 14 years

J C Njau1, S Aboud

  • 1Department of Paediatrics and Child Health, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.

Insights

Tuberculosis (TB) and human immunodeficiency virus (HIV) co-infection affects one-fifth of children. Male gender, young age, and severe immunosuppression are risk factors for TB in HIV-infected children.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Tuberculosis (TB) and human immunodeficiency virus (HIV) co-infection presents a significant global health challenge.
  • Diagnosing TB in children is complex due to non-specific clinical signs, difficult-to-interpret chest radiographs, and unhelpful routine laboratory tests.
  • Current diagnostic approaches often rely on identifying an adult TB case within the household.

Purpose of the Study:

  • To determine the prevalence of TB among HIV-infected children under 14 years old.
  • To identify risk factors associated with TB in this pediatric population.
  • To assess the utility of clinical manifestations and CD4+ T-lymphocyte counts in predicting active TB.

Main Methods:

  • A cross-sectional study was conducted involving 182 HIV-infected children under 14 years at Muhimbili National Hospital, Tanzania.
  • Data collection included socio-demographic information, clinical assessment, tuberculin skin testing, chest radiography, sputum microscopy and culture, and CD4+ T-lymphocyte percentage.
  • Statistical analysis utilized Chi-square tests and odds ratios to identify significant risk factors and associations.

Main Results:

  • The overall prevalence of TB among HIV-infected children was 20.3% (37 out of 182).
  • TB prevalence was significantly higher in males (78.4%) and in children under 24 months (45.9%).
  • Male gender, history of TB contact, and severe immunosuppression were identified as significant risk factors, while antiretroviral therapy use was associated with a decreased risk.

Conclusions:

  • Approximately one-fifth of HIV-infected children in the study had TB co-infection.
  • A low CD4+ T-lymphocyte percentage and the presence of four or more clinical manifestations can aid in predicting active TB in HIV-infected children.
  • Early identification and management of TB in this vulnerable population are crucial public health priorities.
Abstract

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories: